Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 4Phase 4 2Phase 3 1Phase 1 1

Status

Completed 4Terminated 1Suspended 1Recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Carcinoma, Hepatocellular 2Pancreatic Neoplasms 1Liver Neoplasms 1Conversion Disorder 1Colorectal Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Hepatectomy × Clear all
NCT05349331 2026-01-15

WATCH

Sun Yat-sen University

Phase 2 Completed
74 enrolled
Gastrointestinal

Conversion Disorder, Carcinoma, Hepatocellular

NCT03801915 2023-03-21

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
10 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT05471674 2023-02-01

Neoadjuvant Anti-PD1 in HCC

The University of Hong Kong

Phase 2 Completed
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT00153998 2009-02-27

Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

Technische Universität Dresden

Phase 2 Completed
135 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡